Aug 12 (Reuters) - Milestone Pharmaceuticals Inc MIST.O :
* MILESTONE PHARMACEUTICALS REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CLINICAL AND CORPORATE UPDATE
* MILESTONE PHARMACEUTICALS INC - AS OF JUNE 30, 2020, MILESTONE HAD CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS OF $85.4 MILLION
* MILESTONE PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.53